| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049361274 |
| P356 | DOI | 10.1023/B:BREA.0000010670.85915.0F |
| P698 | PubMed publication ID | 14997049 |
| P2093 | author name string | Michael Slater | |
| Julian A Barden | |||
| Suzanne Danieletto | |||
| Angus Gidley-Baird | |||
| Margaret Pooley | |||
| Liew Cheng Teh | |||
| P2860 | cites work | Human Cancer Syndromes: Clues to the Origin and Nature of Cancer | Q22242264 |
| Specific detection of non-functional human P2X(7) receptors in HEK293 cells and B-lymphocytes | Q28182688 | ||
| Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast | Q30651758 | ||
| Studies of apoptosis in breast cancer | Q33806008 | ||
| The pathway of neoplastic transformation of human breast epithelial cells | Q34106242 | ||
| Histological and biological evolution of human premalignant breast disease | Q34249797 | ||
| Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? | Q34827540 | ||
| Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas | Q35745924 | ||
| Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications | Q40915243 | ||
| Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. | Q43669839 | ||
| Markers for the development of early prostate cancer | Q44310403 | ||
| Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. | Q52884542 | ||
| Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast. | Q53891270 | ||
| Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins | Q69020083 | ||
| Cancer risk assessment in benign breast biopsies | Q69618962 | ||
| Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer | Q74088944 | ||
| Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade | Q74141749 | ||
| Detection of preneoplasia in histologically normal prostate biopsies | Q78704271 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-10 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Differentiation between cancerous and normal hyperplastic lobules in breast lesions | |
| P478 | volume | 83 |
| Q42505092 | A phase I clinical trial demonstrates that nfP2X7 -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma |
| Q90826072 | ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival |
| Q92990603 | Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality? |
| Q56828276 | Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors |
| Q82038296 | Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma |
| Q39015711 | Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells |
| Q64912843 | Differential Effects of Purinergic Signaling in Gastric Cancer-Derived Cells Through P2Y and P2X Receptors. |
| Q39885707 | Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis |
| Q61764006 | Extracellular ATP and P2 purinergic signalling in the tumour microenvironment |
| Q37198990 | Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors. |
| Q42316250 | Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells |
| Q38005034 | New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors |
| Q39606672 | P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness |
| Q37279471 | P2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin |
| Q42087948 | P2X(7): a growth-promoting receptor-implications for cancer |
| Q36200053 | P2X7 Receptor Function in Bone-Related Cancer |
| Q34583795 | P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value. |
| Q35500124 | P2X7 mediates ATP-driven invasiveness in prostate cancer cells |
| Q36092896 | P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma |
| Q59321165 | P2X7 receptors are a potential novel target for anti-glioma therapies |
| Q27324419 | Protein Profiling of Bladder Urothelial Cell Carcinoma |
| Q53244075 | The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1/2 signalling pathway. |
| Q33759124 | The purine receptor P2X7R regulates the release of pro-inflammatory cytokines in human craniopharyngioma |
| Q91840488 | The yin and yang functions of extracellular ATP and adenosine in tumor immunity |
| Q34195588 | Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. |
Search more.